RT Journal Article
SR Electronic
T1 Interferon Resistance of Emerging SARS-CoV-2 Variants
JF bioRxiv
FD Cold Spring Harbor Laboratory
SP 2021.03.20.436257
DO 10.1101/2021.03.20.436257
A1 Kejun Guo
A1 Bradley S. Barrett
A1 Kaylee L. Mickens
A1 Kim J. Hasenkrug
A1 Mario L. Santiago
YR 2021
UL http://biorxiv.org/content/early/2021/03/21/2021.03.20.436257.abstract
AB The emergence of SARS-CoV-2 variants with enhanced transmissibility, pathogenesis and resistance to vaccines presents urgent challenges for curbing the COVID-19 pandemic. While Spike mutations that enhance virus infectivity may drive the emergence of these novel variants, studies documenting a critical a role for interferon responses in the early control of SARS-CoV-2 infection, combined with the presence of viral genes that limit these responses, suggest that interferons may also influence SARS-CoV-2 evolution. Here, we compared the potency of 17 different human interferons against 5 viral lineages sampled during the course of the global outbreak that included ancestral and emerging variants. Our data revealed increased interferon resistance in emerging SARS-CoV-2 variants, indicating that evasion of innate immunity is a significant driving force for SARS-CoV-2 evolution. These findings have implications for the increased lethality of emerging variants and highlight the interferon subtypes that may be most successful in the treatment of early infections.Competing Interest StatementThe authors have declared no competing interest.